Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Punjab, Similar States See Benefits From India Tax Cut

This article was originally published in PharmAsia News

Executive Summary

The Indian state of Punjab is expected to be one of the beneficiaries of the federal government's decision to reduce by half the excise duty on drugs. Currently, other states have tax-exempt status, and the planned excise-tax reduction is expected by Punjab and similar states to give them more equality and make them more attractive to drug manufacturers. Some states expect a relocation of some company drug units into non-exempt states. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts